Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Residual Vein Thrombosis Establishes the Optimal Duration of Low Molecular Weight Heparins in Cancer Patients With Deep Vein Thrombosis of the Lower Limbs

NCT00450645 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico as lead sponsor.

NCT NCT00450645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Residual Vein Thrombosis Establishes the Optimal Duration of Low Molecular Weight Heparins in Cancer Patients With Deep Vein Thrombosis of the Lower Limbs
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico
Phase
Phase 4
Overall status
Unknown status
Start date
March 31, 2005
Completion date
March 31, 2011
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, deep vein thrombosis